OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Canagliflozin, a SGLT-2 inhibitor, relieves ER stress, modulates autophagy and induces apoptosis in irradiated HepG2 cells: Signal transduction between PI3K/AKT/GSK-3β/mTOR and Wnt/β-catenin pathways; in vitro
Mohamed Khairy Abdel-Rafei, Noura M. Thabet, Laila Ahmed Rashed, et al.
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 6, pp. 1404-1418
Open Access | Times Cited: 41
Mohamed Khairy Abdel-Rafei, Noura M. Thabet, Laila Ahmed Rashed, et al.
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 6, pp. 1404-1418
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari, Athanasios‐Dimitrios Bakasis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3107-3107
Open Access | Times Cited: 97
Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari, Athanasios‐Dimitrios Bakasis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3107-3107
Open Access | Times Cited: 97
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 83
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 83
SGLT2 Inhibitors as Potential Anticancer Agents
Debasish Basak, David Gamez, Subrata Deb
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1867-1867
Open Access | Times Cited: 37
Debasish Basak, David Gamez, Subrata Deb
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1867-1867
Open Access | Times Cited: 37
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 32
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 32
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential
Min Sun, Jilei Sun, Wei Sun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Min Sun, Jilei Sun, Wei Sun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer
Huan Deng, Yamei Chen, Peijing Li, et al.
Cancer Pathogenesis and Therapy (2022) Vol. 1, Iss. 1, pp. 56-66
Open Access | Times Cited: 37
Huan Deng, Yamei Chen, Peijing Li, et al.
Cancer Pathogenesis and Therapy (2022) Vol. 1, Iss. 1, pp. 56-66
Open Access | Times Cited: 37
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5634-5634
Open Access | Times Cited: 34
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5634-5634
Open Access | Times Cited: 34
Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, et al.
Pharmacological Research (2022) Vol. 181, pp. 106261-106261
Closed Access | Times Cited: 25
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, et al.
Pharmacological Research (2022) Vol. 181, pp. 106261-106261
Closed Access | Times Cited: 25
CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma
Zeyu Hou, Chenzhou Wu, Jinru Tang, et al.
Experimental Cell Research (2024), pp. 113935-113935
Closed Access | Times Cited: 4
Zeyu Hou, Chenzhou Wu, Jinru Tang, et al.
Experimental Cell Research (2024), pp. 113935-113935
Closed Access | Times Cited: 4
Canagliflozin alleviates acetaminophen-induced renal and hepatic injury in mice by modulating the p-GSK3β/Fyn-kinase/Nrf-2 and p-AMPK-α/STAT-3/SOCS-3 pathways
Abeer Bishr, Bassant M. El-Mokadem, Asmaa A. Gomaa
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Abeer Bishr, Bassant M. El-Mokadem, Asmaa A. Gomaa
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Impact of SGLT2 Inhibitors on Survival in Gastrointestinal Cancer Patients Undergoing Chemotherapy and/or Radiotherapy: A Real-World Data Retrospective Cohort Study
Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Advances in sodium-glucose transporter protein 2 inhibitors and tumors
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Marina Takawy, Manal F. Abdelmalek
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access
Marina Takawy, Manal F. Abdelmalek
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access
SGLT2i delays c-Myc-induced HCC progression via targeting mTOR
Huiling Rao, Xiaotong An, Xiaoyan Qu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167805-167805
Closed Access
Huiling Rao, Xiaotong An, Xiaoyan Qu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167805-167805
Closed Access
Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study
Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
MiR-518b Promotes the Tumorigenesis of Hepatocellular Carcinoma by Targeting EGR1 to Regulate PI3K/AKT/mTOR Signaling Pathway
Xinyuan Wang, Juan Li, Jiao Nong, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Xinyuan Wang, Juan Li, Jiao Nong, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Inhibition of glycolysis and stimulation of mitochondrial biogenesis lead to increased ROS levels and cell death in HNF-1ß positive clear cell carcinoma
Naoki Kawahara, Hiroki Kuniyasu, Shiori Mori, et al.
Research Square (Research Square) (2025)
Closed Access
Naoki Kawahara, Hiroki Kuniyasu, Shiori Mori, et al.
Research Square (Research Square) (2025)
Closed Access
Sodium‐Glucose Cotransporter‐2 Inhibitor Suppresses Endoplasmic Reticulum Stress and Oxidative Stress in Diabetic Nephropathy Through Nrf2 Signaling: A Clinical and Experimental Study
Murali Krishna Prasad, Paul Victor, Goutham V. Ganesh, et al.
The Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 3
Murali Krishna Prasad, Paul Victor, Goutham V. Ganesh, et al.
The Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 3
Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism
Ang Dai, Xiaohong Guo, Xiaoqing Yang, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 5, pp. 1328-1337
Open Access | Times Cited: 8
Ang Dai, Xiaohong Guo, Xiaoqing Yang, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 5, pp. 1328-1337
Open Access | Times Cited: 8
USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis
Ying Wang, Xia Luo, Nayiyuan Wu, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 1, pp. 97-107
Open Access | Times Cited: 4
Ying Wang, Xia Luo, Nayiyuan Wu, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 1, pp. 97-107
Open Access | Times Cited: 4
Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis
Daniel J. Huynh, Benjamin D. Renelus, Daniel S. Jamorabo
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Daniel J. Huynh, Benjamin D. Renelus, Daniel S. Jamorabo
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
